发明名称 DOSAGE FOR TREATMENT WITH ANTI-ErbB2 ANTIBODY
摘要 PROBLEM TO BE SOLVED: To provide a method for treatment of disorders characterized by the overexpression of ErbB2.SOLUTION: A method for treatment comprises: administering an effective amount of an anti-ErbB2 antibody to the human patient; administering to the patient an initial dose of at least approximately 5 mg/kg of the anti-ErbB2 antibody; and administering to the patient a plurality of subsequent doses of the antibody in an amount that is approximately the same or less than the initial dose. The initial dose is selected from the group consisting essentially of approximately 6 mg/kg, 8 mg/kg, or 12 mg/kg, wherein the plurality of subsequent doses are at least approximately 2 mg/kg, and wherein the subsequent doses are separated in time from each other by at least one week.
申请公布号 JP2013209389(A) 申请公布日期 2013.10.10
申请号 JP20130100116 申请日期 2013.05.10
申请人 GENENTECH INC 发明人 BAUGHMAN SHARON ANN;SHAK STEVEN
分类号 A61K39/395;A61K31/337;A61K31/704;A61K38/12;A61P15/00;A61P35/00;A61P35/02;A61P43/00;C07K16/28;C07K16/32 主分类号 A61K39/395
代理机构 代理人
主权项
地址